These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 9618265)

  • 1. Effects of tocotrienol on the intracellular translocation and degradation of apolipoprotein B: possible involvement of a proteasome independent pathway.
    Wang Q; Theriault A; Gapor A; Adeli K
    Biochem Biophys Res Commun; 1998 May; 246(3):640-3. PubMed ID: 9618265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-dependent and -independent proteasomal degradation of apoB associated with endoplasmic reticulum and Golgi apparatus, respectively, in HepG2 cells.
    Liao W; Chang BH; Mancini M; Chan L
    J Cell Biochem; 2003 Aug; 89(5):1019-29. PubMed ID: 12874835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitin-proteasome pathway mediates intracellular degradation of apolipoprotein B.
    Yeung SJ; Chen SH; Chan L
    Biochemistry; 1996 Oct; 35(43):13843-8. PubMed ID: 8901527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the endoplasmic reticulum 60 protein ER-60 downregulates apoB100 secretion by inducing its intracellular degradation via a nonproteasomal pathway: evidence for an ER-60-mediated and pCMB-sensitive intracellular degradative pathway.
    Qiu W; Kohen-Avramoglu R; Rashid-Kolvear F; Au CS; Chong TM; Lewis GF; Trinh DK; Austin RC; Urade R; Adeli K
    Biochemistry; 2004 Apr; 43(16):4819-31. PubMed ID: 15096051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine-induced endoplasmic reticulum stress promotes ApoB100 degradation: evidence for Grp78-mediated targeting to proteasomal degradation.
    Qiu W; Kohen-Avramoglu R; Mhapsekar S; Tsai J; Austin RC; Adeli K
    Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):571-7. PubMed ID: 15618547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated Co-translational ubiquitination of apolipoprotein B100. A new paradigm for proteasomal degradation of a secretory protein.
    Zhou M; Fisher EA; Ginsberg HN
    J Biol Chem; 1998 Sep; 273(38):24649-53. PubMed ID: 9733761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of gamma-tocotrienol on ApoB synthesis, degradation, and secretion in HepG2 cells.
    Theriault A; Wang Q; Gapor A; Adeli K
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):704-12. PubMed ID: 10073977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytosolic components are required for proteasomal degradation of newly synthesized apolipoprotein B in permeabilized HepG2 cells.
    Sakata N; Stoops JD; Dixon JL
    J Biol Chem; 1999 Jun; 274(24):17068-74. PubMed ID: 10358059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-hydroxy-3-methylglutaryl coenzyme A reductase is sterol-dependently cleaved by cathepsin L-type cysteine protease in the isolated endoplasmic reticulum.
    Moriyama T; Wada M; Urade R; Kito M; Katunuma N; Ogawa T; Simoni RD
    Arch Biochem Biophys; 2001 Feb; 386(2):205-12. PubMed ID: 11368343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.
    Liao W; Yeung SC; Chan L
    J Biol Chem; 1998 Oct; 273(42):27225-30. PubMed ID: 9765244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on degradative mechanisms mediating post-translational fragmentation of apolipoprotein B and the generation of the 70-kDa fragment.
    Cavallo D; Rudy D; Mohammadi A; Macri J; Adeli K
    J Biol Chem; 1999 Aug; 274(33):23135-43. PubMed ID: 10438483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosinase degradation via two pathways during reverse translocation to the cytosol.
    Mosse CA; Hsu W; Engelhard VH
    Biochem Biophys Res Commun; 2001 Jul; 285(2):313-9. PubMed ID: 11444844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of atorvastatin on the intracellular stability and secretion of apolipoprotein B in HepG2 cells.
    Mohammadi A; Macri J; Newton R; Romain T; Dulay D; Adeli K
    Arterioscler Thromb Vasc Biol; 1998 May; 18(5):783-93. PubMed ID: 9598838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translocational status of ApoB in the presence of an inhibitor of microsomal triglyceride transfer protein.
    Macri J; Kazemian P; Kulinski A; Rudy D; Aiton A; Thibert RJ; Adeli K
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1035-47. PubMed ID: 11027587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
    Wenner C; Lorkowski S; Engel T; Cullen P
    Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution, transport, and degradation of apolipoprotein B-100 in HepG2 cells.
    Sakata N; Phillips TE; Dixon JL
    J Lipid Res; 2001 Dec; 42(12):1947-58. PubMed ID: 11734567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone interactions of the metalloproteinase meprin A in the secretory or proteasomal-degradative pathway.
    Tsukuba T; Kadowaki T; Hengst JA; Bond JS
    Arch Biochem Biophys; 2002 Jan; 397(2):191-8. PubMed ID: 11795871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A two-site model for ApoB degradation in HepG2 cells.
    Wu X; Sakata N; Lele KM; Zhou M; Jiang H; Ginsberg HN
    J Biol Chem; 1997 Apr; 272(17):11575-80. PubMed ID: 9111073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tunicamycin induces ubiquitination and degradation of apolipoprotein B in HepG2 cells.
    Liao W; Chan L
    Biochem J; 2001 Feb; 353(Pt 3):493-501. PubMed ID: 11171045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutting edge: proteasome involvement in the degradation of unassembled Ig light chains.
    O'Hare T; Wiens GD; Whitcomb EA; Enns CA; Rittenberg MB
    J Immunol; 1999 Jul; 163(1):11-4. PubMed ID: 10384092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.